Related references
Note: Only part of the references are listed.Known epigenetic biomarkers for prostate cancer detection and management: exploring the potential of blood-based liquid biopsies
Vera Constancio et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2019)
CT screening for lung cancer: Are we ready to implement in Europe?
Haval Balata et al.
LUNG CANCER (2019)
Subtyping Lung Cancer Using DNA Methylation in Liquid Biopsies
Sandra P. Nunes et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Could infrared thermal imaging be a new diagnostic tool for acute appendicitis?
Sinan Hatipoglu et al.
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2019)
Targeted methylation sequencing of plasma cell-free DNA for cancer detection and classification
L. Liu et al.
ANNALS OF ONCOLOGY (2018)
Potential of quantitative SEPT9 and SHOX2 methylation in plasmatic circulating cell-free DNA as auxiliary staging parameter in colorectal cancer: a prospective observational cohort study
Julia Bergheim et al.
BRITISH JOURNAL OF CANCER (2018)
Cell-Free Circulating Methylated SEPT9 for Noninvasive Diagnosis and Monitoring of Colorectal Cancer
Bo Fu et al.
DISEASE MARKERS (2018)
A novel DNA methylation panel accurately detects colorectal cancer independently of molecular pathway
Micaela Freitas et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
Two plasma microRNA panels for diagnosis and subtype discrimination of lung cancer
Shaohua Lu et al.
LUNG CANCER (2018)
CancerDetector: ultrasensitive and non-invasive cancer detection at the resolution of individual reads using cell-free DNA methylation sequencing data
Wenyuan Li et al.
NUCLEIC ACIDS RESEARCH (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Improving the Specificity of PSA Screening with Serum and Urine Markers
James T. Kearns et al.
CURRENT UROLOGY REPORTS (2018)
Cell-Free DNA Methylation of Selected Genes Allows for Early Detection of the Major Cancers in Women
Sandra P. Nunes et al.
CANCERS (2018)
A urine-based DNA methylation assay, ProCUrE, to identify clinically significant prostate cancer
Fang Zhao et al.
CLINICAL EPIGENETICS (2018)
Comparing diagnostic and prognostic performance of two-gene promoter methylation panels in tissue biopsies and urines of prostate cancer patients
Catarina Moreira-Barbosa et al.
CLINICAL EPIGENETICS (2018)
Effects of Volume CT Lung Cancer Screening: Mortality Results of the NELSON Randomised-Controlled Population Based Trial
H. De Koning et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Early Detection of Lung Cancer Using DNA Promoter Hypermethylation in Plasma and Sputum
Alicia Hulbert et al.
CLINICAL CANCER RESEARCH (2017)
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
Nicolas Mottet et al.
EUROPEAN UROLOGY (2017)
Validation of the SHOX2/PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease
Gunter Weiss et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
The performance of the SEPT9 gene methylation assay and a comparison with other CRC screening tests: A meta-analysis
Lele Song et al.
SCIENTIFIC REPORTS (2017)
CancerLocator: non-invasive cancer diagnosis and tissue-of-origin prediction using methylation profiles of cell-free DNA
Shuli Kang et al.
GENOME BIOLOGY (2017)
SOX17 promoter methylation in plasma circulating tumor DNA of patients with non-small cell lung cancer
Ioanna Balgkouranidou et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2016)
Evaluation of prostate cancer antigen 3 for detecting prostate cancer: a systematic review and meta-analysis
Yong Cui et al.
SCIENTIFIC REPORTS (2016)
Colorectal cancer development and advances in screening
Karen Simon
CLINICAL INTERVENTIONS IN AGING (2016)
Epigenetic biomarkers in the blood of patients with urological malignancies
Joerg Ellinger et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2015)
Colorectal Cancer Screening
Andrew A. Plumb et al.
SEMINARS IN ROENTGENOLOGY (2015)
Diagnostic and prognostic epigenetic biomarkers in cancer
Pedro Costa-Pinheiro et al.
EPIGENOMICS (2015)
Real-time monitoring efficiency and toxicity of chemotherapy in patients with advanced lung cancer
Hong Wang et al.
CLINICAL EPIGENETICS (2015)
Methylation of RASSF1A and CDH13 Genes in Individualized Chemotherapy for Patients with Non-small Cell Lung Cancer
Xu Zhai et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Epigenetic biomarkers in urological tumors: A systematic review
Carmen Jeronimo et al.
CANCER LETTERS (2014)
Septin 9 promoter region methylation in free circulating DNA-potential role in noninvasive diagnosis of lung cancer: preliminary report
Tomasz Powrozek et al.
MEDICAL ONCOLOGY (2014)
Lung Cancer Screening: Advantages, Controversies, and Applications
Prema Nanavaty et al.
CANCER CONTROL (2014)
Aberrant methylation of NPY, PENK, and WIF1 as a promising marker for blood-based diagnosis of colorectal cancer
Jean-Pierre Roperch et al.
BMC CANCER (2013)
Usefulness of plasma epigenetic changes of five major genes involved in the pathogenesis of colorectal cancer
Seung-Chul Pack et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2013)
Potentialities of aberrantly methylated circulating DNA for diagnostics and post-treatment follow-up of lung cancer patients
Anastasia A. Ponomaryova et al.
LUNG CANCER (2013)
Epigenetic biomarkers in colorectal cancer diagnostics
James B. Rawson et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2012)
DNA methylation patterns in blood of patients with colorectal cancer and adenomatous colorectal polyps
Elisa Cassinotti et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Classification of the Four Main Types of Lung Cancer Using a MicroRNA-Based Diagnostic Assay
Shlomit Gilad et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2012)
Measurement of GSTP1 promoter methylation in body fluids may complement PSA screening: a meta-analysis
T. Wu et al.
BRITISH JOURNAL OF CANCER (2011)
An Epigenetic Marker Panel for Detection of Lung Cancer Using Cell-Free Serum DNA
Shahnaz Begum et al.
CLINICAL CANCER RESEARCH (2011)
Screening for Prostate Cancer
Richard M. Hoffman
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
Denise R. Aberle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
From discovery to the clinic: the novel DNA methylation biomarker mSEPT9 for the detection of colorectal cancer in blood
Shannon R. Payne
EPIGENOMICS (2010)
Aberrant Methylation of APC, MGMT, RASSF2A, and Wif-1 Genes in Plasma as a Biomarker for Early Detection of Colorectal Cancer
Bo Bin Lee et al.
CLINICAL CANCER RESEARCH (2009)
Multimarker Circulating DNA Assay for Assessing Blood of Prostate Cancer Patients
Eiji Sunami et al.
CLINICAL CHEMISTRY (2009)
Molecular origins of cancer: Epigenetics in cancer
Manel Esteller
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Detection of RASSF1A promoter hypermethylation in serum from gastric and colorectal adenocarcinoma patients
Yu-Cai Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer
Joerg Ellinger et al.
PROSTATE (2008)
Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma
Han-Shui Hsu et al.
CANCER (2007)
Identification of epigenetic aberrant promoter methylation of RASSF1A in serum DNA and its clinicopathological significance in lung cancer
Yucai Wang et al.
LUNG CANCER (2007)
Identifying genes that contribute most to good classification in microarrays
Stuart G. Baker et al.
BMC BIOINFORMATICS (2006)
Optimal cut-point and its corresponding youden index to discriminate individuals using pooled blood samples
EF Schisterman et al.
EPIDEMIOLOGY (2005)
Share Paper
